Agranulocytosis in anti-thyroid medications / Paulyn T. Manjares.
Language: English Publication details: Fairview, Quezon City Department of Medicine, FEU-NRMF, 2008Description: (in folder)Content type:- text
- unmediated
- volume
- MED20080001
Item type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
Research | Far Eastern University - Nicanor Reyes Medical Foundation Research | MED20080001 (Browse shelf(Opens below)) | Available | R000139 |
Browsing Far Eastern University - Nicanor Reyes Medical Foundation shelves, Shelving location: Research Close shelf browser (Hides shelf browser)
ABSTRACT: Agranulocytosis is a rare complication of antithyroid drugs. Agranulocytosis is defined as absolute neutropil count, ANC <500x10/l and may develop in 0.2-0.5% of patients taking antithyroid drugs.A case of L.S., 35 y/o female admitted due to fever diagnosed to have hyperthyroidism last 2000 maintained on Tapazole irregularly taken, Patient was taking Strumazole for 1 month. PE: (+) exedates and hypermic pharyngeal wall, thyroid gland palpable, bilateral; adynamic precordium, tachcardic and regular rhythm. Neurologic Exam : unremarkable. In the ward, patient was given Ceftazidime, G-CSF, Paracetamol, Clindamycin, Propranolol, and Multivitamins. Prior to discharge, patient had RAI at 6 MCI
Research - Department of Medicine
There are no comments on this title.